Cisplatin shortage results in substitution of more expensive treatments : Drug cost analysis

Lam, Michael; Olivier, Timothée; Haslam, Alyson; Tuia, Jordan; Prasad, Vinay

doi:10.1016/j.ejca.2024.114019

Scientific article

Letter

English

Cisplatin shortage results in substitution of more expensive treatments : Drug cost analysis

ContributorsLam, Michael; Olivier, Timothée; Haslam, Alyson; Tuia, Jordan; Prasad, Vinay

Published inEuropean journal of cancer, vol. 202, 114019

Publication date2024-05

First online date2024-03-16

Keywords

Humans
Cisplatin / therapeutic use
Lung Neoplasms / drug therapy
Vinblastine
Costs and Cost Analysis
Cost-Benefit Analysis
Antineoplastic Combined Chemotherapy Protocols

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Citation (ISO format)

LAM, Michael et al. Cisplatin shortage results in substitution of more expensive treatments : Drug cost analysis. In: European journal of cancer, 2024, vol. 202, p. 114019. doi: 10.1016/j.ejca.2024.114019

Article (Published version)

CC BY-4.0

Identifiers

PID : unige:183966
DOI : 10.1016/j.ejca.2024.114019
PMID : 38522156

Additional URL for this publicationhttps://www.sciencedirect.com/science/article/pii/S0959804924006750

Journal ISSN0959-8049

31views

56downloads

Creation25/02/2025 11:08:55

First validation19/03/2025 13:35:36

Update19/03/2025 13:41:10

Status update19/03/2025 13:41:10

Last indexation19/03/2025 13:41:13

Archive ouverte UNIGE

Cisplatin shortage results in substitution of more expensive treatments : Drug cost analysis

Technical informations